2m 2m 2m 2m 2m 2m 2m
- $1.2BMarket Cap
- -68.19%1-Year Change
- Medical DevicesIndustry
INSPIRE MED SYS (INSP)
Key Performance
More- Earnings Score: 96
- Momentum Score: 20
- True Yield: N/A
- Financial Health Score: 81
Latest Research & News
Inspire Medical Systems, Inc. Announces Presence at SLEEP 2026 and Publication of PREDICTOR Study
Inspire Medical Systems presented new clinical data at SLEEP 2026 demonstrating the effectiveness of its Inspire V hypoglossal nerve stimulation system for obstructive sleep apnea treatment. Key findings include significant reductions in hypoxic burden, improved cardiovascular outcomes compared to CPAP therapy, and higher patient adherence rates. The company also published studies identifying predictors for therapy eligibility and presented results from its 5,000-patient ADHERE registry showing 62% median AHI reduction.
06/16/2026, 8:00 AM • GlobeNewswire
Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2026 MedTech Innovation Spotlight
Inspire Medical Systems announced that its management team will participate in the Wells Fargo 2026 MedTech Innovation Spotlight on June 26, 2026 at 10:00 a.m. Eastern Time. The company, which develops minimally invasive solutions for obstructive sleep apnea treatment, will present via live webcast with a replay available for two weeks.
06/12/2026, 8:00 AM • GlobeNewswire
U.S. stock futures rose on Tuesday following President Trump's announcement of 'Project Freedom' to reopen commercial shipping through the Strait of Hormuz, amid US-Iran tensions. Key movers included Duolingo (down 12.77% despite beating estimates due to weak guidance), Pinterest (up 16.59% on strong Q1 results), AMD (up 1.94% ahead of earnings), and Inspire Medical Systems (down 21.04% after narrowing revenue guidance). Analysts remain optimistic on tech stocks driven by AI investments and strong corporate earnings.
05/05/2026, 8:34 AM • Benzinga
U.S. stock futures rose on Tuesday following President Trump's announcement of 'Project Freedom' to reopen commercial shipping through the Strait of Hormuz, amid US-Iran military tensions. Key movers included Duolingo (down 12.77% despite beating estimates due to weak guidance), Pinterest (up 16.59% on strong Q1 results), AMD (up 1.94% ahead of earnings), and Inspire Medical Systems (down 21.04% after narrowing revenue guidance). Analysts remain optimistic on technology stocks driven by AI investments and strong corporate earnings.
05/05/2026, 5:19 AM • Benzinga
Inspire Medical Systems, Inc. to Report First Quarter 2026 Financial Results on May 4, 2026
Inspire Medical Systems announced it will release Q1 2026 financial results on May 4, 2026, followed by a management conference call at 5:00 p.m. ET. The company will discuss financial performance and recent business developments. A webcast will be available for investors, with a replay archived for two weeks.
04/06/2026, 8:00 AM • GlobeNewswire
These 9 Oversold Stocks Are Significantly Undervalued - Perfect Time to Buy?
The article identifies 9 oversold US stocks trading 30.7% to 66.3% below estimated fair value amid market volatility driven by Middle East tensions and inflation concerns. Using a value investing strategy based on sharp year-to-date declines, proximity to 52-week lows, oversold RSI signals, and undervaluation metrics, the analysis highlights stocks with strong fundamentals that have been excessively sold off, presenting potential rebound opportunities for patient investors.
03/26/2026, 1:35 PM • Investing
These 9 Oversold Stocks Are Significantly Undervalued - Perfect Time to Buy?
The article identifies 9 US stocks that have fallen 25-43% year-to-date, show oversold technical signals, and trade 30-66% below estimated fair value. In a volatile market environment marked by Middle East tensions and inflation concerns, the author argues these stocks present value investing opportunities. Two specific examples highlighted are Upwork (a freelancing platform) and Inspire Medical Systems (a neurostimulation device maker), both facing short-term pressure despite solid fundamentals.
03/26/2026, 11:37 AM • Investing
These 9 Oversold Stocks Are Significantly Undervalued - Perfect Time to Buy?
The article identifies 9 US stocks that have fallen 25-43% year-to-date, showing oversold signals and trading 30-66% below estimated fair value. In a volatile market environment marked by Middle East tensions and inflation concerns, the author argues these stocks present value investing opportunities for patient investors. Two specific examples highlighted are Upwork (a freelancing platform) and Inspire Medical Systems (a neurostimulation device maker), both facing short-term pressure despite solid fundamentals.
03/26/2026, 10:14 AM • Investing
These 9 Oversold Stocks Are Significantly Undervalued - Perfect Time to Buy?
The article identifies 9 US stocks that have fallen 25-43% year-to-date, show oversold technical signals, and trade 30-66% below estimated fair value. Using a value investing strategy focused on sharp declines, proximity to 52-week lows, low RSI indicators, and undervaluation metrics, the article highlights Upwork and Inspire Medical Systems as examples of strong businesses under short-term pressure with rebound potential amid current market volatility driven by Middle East tensions and inflation concerns.
03/26/2026, 6:46 AM • Investing
These 9 Oversold Stocks Seem Significantly Undervalued - Perfect Time to Buy?
The article identifies 9 US stocks that have fallen 25-43% year-to-date, showing oversold technical signals while trading 30-66% below estimated fair value. In a volatile market environment marked by Middle East tensions and high interest rates, the author argues these stocks present value investing opportunities for patient investors. Two highlighted examples are Upwork, a freelancing platform facing short-term growth concerns but with improving profitability, and Inspire Medical Systems, a neurostimulation device maker with strong fundamentals in a growing market.
03/26/2026, 5:05 AM • Investing
A class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) alleging that the company made materially false and misleading statements regarding market demand for Inspire V and its readiness for product launch. The lawsuit covers investors who purchased securities between August 6, 2024 and August 4, 2025. The law firm is seeking to recover damages for alleged violations of federal securities laws.
01/05/2026, 12:00 PM • GlobeNewswire
A class action securities fraud lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) alleging the company misled investors about its Inspire V device launch readiness. The company failed to prepare clinicians and payors for the rollout, resulting in significant delays and weak demand. On August 4, 2025, Inspire disclosed the launch faced an 'elongated timeframe' and reduced 2025 earnings guidance by over 80%, causing the stock to drop 32% from $129.95 to $87.91 per share. The deadline for investors to request lead plaintiff status is January 5, 2026.
01/04/2026, 7:08 AM • GlobeNewswire
Rosen Law Firm is reminding investors in Gauzy Ltd., Klarna Group plc, and Inspire Medical Systems, Inc. about upcoming deadlines to join securities class action lawsuits. The firm is seeking lead plaintiffs for cases involving alleged false statements and material omissions by company defendants.
01/03/2026, 12:07 PM • GlobeNewswire
Rosen Law Firm has filed securities class action lawsuits against multiple companies. The primary case involves Klarna Group plc, alleging the company made false statements in its September 2025 IPO registration statement by understating risks related to loss reserves for buy-now-pay-later loans. The firm is seeking lead plaintiffs with a February 20, 2026 deadline. Similar class actions have been filed against Inspire Medical Systems and agilon health.
01/03/2026, 11:26 AM • GlobeNewswire
Rosen Law Firm announces a securities class action lawsuit against Inspire Medical Systems, Inc. (NYSE: INSP) for investors who purchased stock between August 6, 2024 and August 4, 2025. The lawsuit alleges that defendants misrepresented key facts about the Inspire V sleep apnea device, including actual market demand and launch readiness. The lead plaintiff deadline is January 5, 2026.
01/03/2026, 11:00 AM • GlobeNewswire
Peers
Statistics
MoreInformation as of 06/22/2026
Company Profile
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Key Executives
- Timothy Herbert
- Carlton W. Weatherby
- Bryan K. Phillips
- John C. Rondoni
- Jason Kelly
Current Ownership Distribution
- Institutions553.9M (75.39%)
- Mutual Funds179.5M (24.44%)
- Insiders1.3M (0.18%)
- Other0 (0.00%)